{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"BE6A LUNG-01","nct_id":"NCT06012435","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=be6a-lung-01-nct06012435. The price is an estimate of verified HCP statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified HCP statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"sigvotatug vedotin monotherapy","label":"Experimental Arm","type":"EXPERIMENTAL"},{"description":"Docetaxel monotherapy","label":"Control Arm","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2028-05-17","type":"ESTIMATED"},"conditions":["Carcinoma, Non-Small-Cell Lung"],"enrollment":{"count":762,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"sigvotatug vedotin","otherNames":["SGN-B6A; PF-08046047"],"type":"DRUG"},{"name":"docetaxel","otherNames":[],"type":"DRUG"}],"last_update":"2026-07-23","lead_sponsor":"Seagen, a wholly owned subsidiary of Pfizer","official_title":"A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY TO EVALUATE SIGVOTATUG VEDOTIN COMPARED WITH DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (BE6A LUNG-01)","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2026-05-18","type":"ACTUAL"},"primary_outcomes":[{"measure":"Overall survival (OS) between the experimental arm (sigvotatug vedotin) and control arm (docetaxel)","timeFrame":"Approximately 5 years"}],"references":[],"start_date":{"date":"2024-02-21","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer","url":"https://clinicaltrials.gov/study/NCT06012435"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/be6a-lung-01-nct06012435"}